Hamza, S. A., Haddad, N. I. A., & Gawwam, G. A. (2026). The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study. INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES, 335-345. https://doi.org/10.29284/x4mwhb26